Hosted on MSN
Core Laboratories outlines Q3 2025 revenue guidance of $127.5M-$134.5M amid margin improvements and global expansion
CEO Lawrence V. Bruno highlighted that "Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic ...
Hosted on MSN
Core Laboratories projects Q4 2025 revenue of $132M–$136M as international demand drives growth
Gwendolyn Schreffler, Senior Vice President, projected Core's fourth quarter 2025 revenue to range from $132 million to $136 million with operating income of $14 million to $16.1 million and operating ...
HOUSTON, Sept. 30, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") announced today the acquisition of Brazil-based integrated geological services company, Solintec. For more than three decades, ...
probability of performance condition for certain executive's share awards. (2) Three months ended June 30, 2025 and September 30, 2025 includes the write-down of inventory. (3) Three months ended June ...
Most readers would already be aware that Core Laboratories' (NYSE:CLB) stock increased significantly by 46% over the past three months. Given that the market rewards strong financials in the long-term ...
Fintel reports that on March 12, 2025, Citigroup upgraded their outlook for Core Laboratories (NYSE:CLB) from Sell to Neutral. As of March 4, 2025, the average one-year price target for Core ...
Core Laboratories (CLB) came out with quarterly earnings of $0.25 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.22 per share a year ago. These figures are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results